Sangdon Han

1.0k total citations · 1 hit paper
15 papers, 708 citations indexed

About

Sangdon Han is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sangdon Han has authored 15 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sangdon Han's work include Pituitary Gland Disorders and Treatments (4 papers), Receptor Mechanisms and Signaling (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Sangdon Han is often cited by papers focused on Pituitary Gland Disorders and Treatments (4 papers), Receptor Mechanisms and Signaling (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Sangdon Han collaborates with scholars based in United States, Denmark and Germany. Sangdon Han's co-authors include Robert M. Jones, Kaare V. Grunddal, Stefan Offermanns, M. Hauge, Steen Seier Poulsen, Maja S. Engelstoft, Mark K. Nøhr, Andreas Gille, Anna Sofie Husted and Kristoffer L. Egerod and has published in prestigious journals such as Cancer Research, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Sangdon Han

14 papers receiving 698 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

GPR41/FFAR3 and GPR43/FFAR2 as Cosensors for Short-Chain Fatty Acids in Enteroendocrine Cells vs FFAR3 in Enteric Neurons and FFAR2 in Enteric Leukocytes

2013 448 citations Mark K. Nøhr, M. Hauge et al. Endocrinology profile →

Peers

Sangdon Han

PHYSI

PHARM

EDM

SURGE

Marta Sobczak Poland

Sabine L. Lahrichi United States

Nathaniel Wallace United States

Cyril Martin Canada

Hitoshi Doihara Japan

Francesco Maiello Italy

Antonio Steardo Italy

Caroline Turcotte Canada

Niels Wellner Denmark

Hiroyuki Ohshiro Japan

Marta Sobczak Poland

Sangdon Han

276 ×0.7

214 ×0.9

PHYSI

210 ×1.6

PHARM

73 ×0.6

EDM

134 ×1.1

SURGE

Citations per year, relative to Sangdon Han Sangdon Han (= 1×) peers Marta Sobczak

Countries citing papers authored by Sangdon Han

Since Specialization

Citations

This map shows the geographic impact of Sangdon Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sangdon Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sangdon Han more than expected).

Fields of papers citing papers by Sangdon Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sangdon Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sangdon Han. The network helps show where Sangdon Han may publish in the future.

Co-authorship network of co-authors of Sangdon Han

This figure shows the co-authorship network connecting the top 25 collaborators of Sangdon Han. A scholar is included among the top collaborators of Sangdon Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sangdon Han. Sangdon Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kim, Nam Hee, et al.. (2024). Abstract LB426: Evidence for a role of GPR35 in IDO1-mediated tumor immune escape by regulating Hippo-YAP pathway. Cancer Research. 84(7_Supplement). LB426–LB426.

Han, Sangdon, Ana Karin Kusnetzow, Greg J. Reinhart, et al.. (2024). Discovery of CRN04894: A Novel Potent Selective MC2R Antagonist. ACS Medicinal Chemistry Letters. 15(4). 478–485. 5 indexed citations

Kim, Sun Hee, Sangdon Han, Elizabeth Rico-Bautista, et al.. (2022). Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinism. Bioorganic & Medicinal Chemistry Letters. 71. 128807–128807. 2 indexed citations

Markison, Stacy, Sangdon Han, Mi Chen, et al.. (2022). Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist. ACS Medicinal Chemistry Letters. 14(1). 66–74. 15 indexed citations

Fowler, Melissa, Ana Karin Kusnetzow, Sangdon Han, et al.. (2021). Effects of CRN04894, a Nonpeptide Orally Bioavailable ACTH Antagonist, on Corticosterone in Rodent Models of ACTH Excess. Journal of the Endocrine Society. 5(Supplement_1). A167–A167. 4 indexed citations

Han, Sangdon, Ana Karin Kusnetzow, Julie Nguyen, et al.. (2020). Discovery of nonpeptide 3,4-dihydroquinazoline-4-carboxamides as potent and selective sst2 agonists. Bioorganic & Medicinal Chemistry Letters. 30(17). 127391–127391. 5 indexed citations

Kusnetzow, Ana Karin, Sangdon Han, Melissa Fowler, et al.. (2020). MON-176 Discovery and Identification of Late Stage Selective Nonpeptide ACTH Antagonists for the Treatment of Cushing’s Disease, Ectopic ACTH Secreting Tumors, and Congenital Adrenal Hyperplasia. Journal of the Endocrine Society. 4(Supplement_1). 4 indexed citations

Kusnetzow, Ana Karin, Melissa Fowler, Greg J. Reinhart, et al.. (2019). SAT-364 Nonpeptide Orally-Bioavailable ACTH Antagonists: Suppression of ACTH-Induced Corticosterone Secretion and Adrenal Hypertrophy in Rats. Journal of the Endocrine Society. 3(Supplement_1). 4 indexed citations

Gaidarov, Ibragim, Todd L. Anthony, Joel Gatlin, et al.. (2018). Embelin and its derivatives unravel the signaling, proinflammatory and antiatherogenic properties of GPR84 receptor. Pharmacological Research. 131. 185–198. 49 indexed citations

10.

Han, Sangdon, Lars Thoresen, Jae‐Kyu Jung, et al.. (2017). Discovery of APD371: Identification of a Highly Potent and Selective CB₂Agonist for the Treatment of Chronic Pain. ACS Medicinal Chemistry Letters. 8(12). 1309–1313. 33 indexed citations

11.

Buzard, Daniel J., Thomas O. Schrader, Xiuwen Zhu, et al.. (2014). Design and synthesis of new tricyclic indoles as potent modulators of the S1P1 receptor. Bioorganic & Medicinal Chemistry Letters. 25(3). 659–663. 13 indexed citations

12.

Han, Sangdon, Jayant Thatte, Daniel J. Buzard, & Robert M. Jones. (2013). Therapeutic Utility of Cannabinoid Receptor Type 2 (CB₂) Selective Agonists. Journal of Medicinal Chemistry. 56(21). 8224–8256. 115 indexed citations

13.

Nøhr, Mark K., M. Hauge, Andreas Gille, et al.. (2013). GPR41/FFAR3 and GPR43/FFAR2 as Cosensors for Short-Chain Fatty Acids in Enteroendocrine Cells vs FFAR3 in Enteric Neurons and FFAR2 in Enteric Leukocytes. Endocrinology. 154(10). 3552–3564. 448 indexed citations breakdown →

14.

Buzard, Daniel J., Juerg Lehmann, Sangdon Han, & Robert M. Jones. (2012). GPR119 Agonists 2009–2011. Pharmaceutical Patent Analyst. 1(3). 285–299. 8 indexed citations

15.

Semple, Graeme, Thuy-Anh Tran, Sangdon Han, et al.. (2009). Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: In vitro profiling and in vivo evaluation. Bioorganic & Medicinal Chemistry Letters. 19(21). 6166–6171. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact